ETN101 / Etnova Therap  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ETN101 / Etnova Therap
NCT06326502: A Safety and Efficacy Study of Multiple Tyrosine Kinase Inhibitor Drug (ETN101) in Advanced Hepatocellular Carcinoma

Recruiting
1
50
RoW
ETN101
Etnova Therapeutics Corp.
Hepatocellular Carcinoma, Advanced Hepatocellular Carcinoma, Liver Cancer
03/27
06/27

Download Options